Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors

Journal of Virology

Volumn 75, Issue 1, 2001, Pages 269-277

  Sarukhan, A ^a   Camugli, S ^a   Gjata, B ^a   Von Boehmer, H ^a   Danos, O ^a   Jooss, K ^a  

^a GÉNÉTHON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; VIRUS HEMAGGLUTININ; VIRUS PROTEIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; DENDRITIC CELL; GENE TRANSFER; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; T LYMPHOCYTE ACTIVATION; TRANSGENE; VACCINATION; VIRUS RECOMBINANT;

ANIMALS; ANTIGENS, CD40; CD40 LIGAND; DEPENDOVIRUS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 0034749458     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.1.269-277.2001     Document Type: Article

References (43)

1. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay
2. Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration
3. In the absence of a CD40 signal, B cells are tolerogenic
4. Cross-presentation: A general mechanism for CTL immunity and tolerance
5. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope
6. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)
7. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
8. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy
9. Recombinant adeno-associated virus for muscle directed gene therapy
10. Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice
11. Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector
12. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells
13. Crosstolerance: A pathway for inducing tolerance to peripheral tissue antigens
14. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
15. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
16. Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver
17. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fiber
18. Priming of helper T cell-dependent antibody responses by hemagglutinin-transgenic B cells
19. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver
20. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
21. + single positive cells with a class II major histocompatibility complex-restricted receptor
22. Major histocompatibility complex class I-restricted cross-presentation is biased toward high-dose antigens and those released during cellular destruction
23. + T cells
24. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
25. rAAV vector-mediated sarcoglycan gene transfer in a hamster model for limb girdle muscular dystrophy
26. Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer
27. Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D
28. A 39-kDa protein on activated helper T cells bind CD40 and transduces the signal for cognate activation of B cells
29. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction
30. Adeno-associated virus-mediated gene delivery
31. Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice
32. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion
33. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-deficient adenovirus vector
34. Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle
35. Sustained correction of bleeding disorder in hemophilia B mice by gene therapy
36. Specific low-affinity recognition of MHC complex plus peptide by soluble T-cell receptor
37. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
38. Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy
39. Production of high-titer recombinant adeno-associated virus vector in the absence of helper adenovirus
40. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo
41. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues
42. CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40
43. Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule